-+ 0.00%
-+ 0.00%
-+ 0.00%

RENOVORX ADVANCES TAMP™ INTO BORDERLINE RESECTABLE PANCREATIC CANCER WITH FIRST PATIENT ENROLLED IN INVESTIGATOR-INITIATED PRISM-TAMP TRIAL

Reuters·10/07/2026 12:30:01

Please log in to view news